RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law